Send the following on WhatsApp
Continue to ChatAtG Therapeutics Appoints Dr. Itziar Canamasas as New CEO to Drive Development of Cancer Metabolic Adaptation Inhibitors https://www.atgtx.com/news/2023/03/atg-therapeutics-appoints-dr-itziar-canamasas-as-new-ceo-to-drive-development-of-cancer-metabolic-adaptation-inhibitors/